Maria Grazia Valsecchi

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi et al. · Blood · 2010 · 786 citations · Full text

Medicine, Hematology, Oncology +11

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial

Rob Pieters, Martin Schrappe, Paola De Lorenzo et al. · The Lancet · 2007 · 653 citations

Medicine, Hematology, Pediatrics +14

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Martin Schrappe, Maria Grazia Valsecchi, Claus R. Bartram et al. · Blood · 2011 · 438 citations · Full text

Life Sciences, Immunology, Immunotherapy +3

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Carlo Gambacorti‐Passerini, Laura Antolini, François‐Xavier Mahon et al. · JNCI Journal of the National Cancer Institute · 2011 · 428 citations · Full text

Life Sciences, Hematology, Pharmacotherapy +15